Published in Dig Dis Sci on May 20, 2014
Characterizing the prevalence of chromosome instability in interval colorectal cancer. Neoplasia (2015) 0.81
Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain. Gastroenterol Res Pract (2015) 0.78
Clinical and Biological Features of Interval Colorectal Cancer. Clin Endosc (2017) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
Genetic instabilities in human cancers. Nature (1998) 22.76
Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Genetic instability in colorectal cancers. Nature (1997) 12.51
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med (2003) 12.17
Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res (1997) 8.88
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol (2008) 7.45
Microsatellite instability in colorectal cancer. Gastroenterology (2010) 7.39
CpG island methylator phenotype in cancer. Nat Rev Cancer (2004) 7.13
Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J (2000) 6.55
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc (2005) 6.41
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA (2006) 6.26
The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol (2006) 6.16
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc (2003) 5.52
Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19
Are there two sides to colorectal cancer? Int J Cancer (2002) 5.18
Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol (2004) 5.09
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet (2000) 5.04
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res (2002) 4.46
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37
Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology (1997) 4.32
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology (2010) 4.25
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A (2007) 4.16
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol (2000) 3.98
Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74
Chromosomal instability confers intrinsic multidrug resistance. Cancer Res (2011) 3.70
Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol (2003) 3.59
Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A (2008) 3.52
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res (2003) 3.39
Serrated adenomatous polyposis in humans. Gastroenterology (1996) 3.30
Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology (1996) 3.30
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer (2003) 3.21
Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet (2007) 3.12
Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol (2010) 2.97
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut (2008) 2.68
CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res (2008) 2.65
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc (2005) 2.63
Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc (1997) 2.62
The chromosomal instability pathway in colon cancer. Gastroenterology (2010) 2.59
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol (2006) 2.55
Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy (2004) 2.52
Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol (2010) 2.44
Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol (2010) 2.43
Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst (2000) 2.37
Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol (2009) 2.36
Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol (2004) 2.27
Microsatellite instability in interval colon cancers. Gastroenterology (2006) 2.23
Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol (2006) 2.21
CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol (2009) 2.17
Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer (2010) 2.16
Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol (2000) 2.03
Interval cancers after negative colonoscopy: population-based case-control study. Gut (2011) 1.97
Lynch syndrome genes. Fam Cancer (2005) 1.94
Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst (1993) 1.94
Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg (2000) 1.93
Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol (2003) 1.90
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89
Multiple genetic alterations in distal and proximal colorectal cancer. Lancet (1989) 1.87
Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol (2003) 1.82
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol (2001) 1.79
Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A (2009) 1.72
Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut (2013) 1.69
Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.68
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. Hum Mol Genet (2004) 1.66
CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int (2011) 1.62
Does a negative screening colonoscopy ever need to be repeated? Gut (2006) 1.61
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer (1997) 1.57
Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer (2000) 1.56
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut (2011) 1.45
Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn (2006) 1.43
Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol (2010) 1.42
Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2012) 1.38
Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol (2004) 1.30
Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res (2006) 1.28
Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer (2008) 1.27
DNA mismatch repair and cancer. Gastroenterology (1995) 1.25
Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol (2011) 1.23
Invasive colorectal cancer detected up to 3 years after a colonoscopy negative for cancer. Endoscopy (2003) 1.23
Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol (2011) 1.21
Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. J Clin Oncol (2012) 1.17
Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68
Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51
Recommendations on screening for cervical cancer. CMAJ (2013) 3.32
Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol (2012) 2.09
Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. J Biol Chem (2008) 1.99
Recommendations on screening for colorectal cancer in primary care. CMAJ (2016) 1.52
Estimating benefits and harms of screening across subgroups: the Canadian Task Force on Preventive Health Care integrates the GRADE approach and overcomes minor challenges. J Clin Epidemiol (2012) 1.46
The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol (2012) 1.42
A survey of sedation practices for colonoscopy in Canada. Can J Gastroenterol (2011) 1.42
Process for guideline development by the reconstituted Canadian Task Force on Preventive Health Care. CMAJ (2012) 1.39
Survey of access to gastroenterology in Canada: the SAGE wait times program. Can J Gastroenterol (2010) 1.37
Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics. Can J Gastroenterol (2013) 1.36
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. PLoS Genet (2011) 1.18
Pyogenic granuloma: an unusual cause of massive gastrointestinal bleeding from the small bowel. Can J Gastroenterol (2009) 1.17
Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement. Can J Gastroenterol (2008) 1.15
Recommendations on screening for lung cancer. CMAJ (2016) 1.13
Prevalence and severity of dysmenorrhea: a problem related to menstruation, among first and second year female medical students. Indian J Physiol Pharmacol (2009) 1.08
An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development. PLoS Genet (2013) 1.00
Oral bisphosphonates and colorectal cancer: cumulative dose and duration of use are important predictors of effect. Clin Gastroenterol Hepatol (2013) 0.99
Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development. Dev Biol (2004) 0.99
A survey of the practice of after-hours and emergency endoscopy in Canada. Can J Gastroenterol (2012) 0.98
High-resolution ultrasonography in the diagnosis and intraoperative management of peripheral nerve lesions. J Neurosurg (2010) 0.98
Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant. J Am Chem Soc (2008) 0.97
Canadian Task Force on Preventive Health Care: we're back! Can Fam Physician (2012) 0.96
Geographical variation and factors associated with colorectal cancer mortality in a universal health care system. Can J Gastroenterol Hepatol (2014) 0.95
Peritonitis after gastrostomy tube replacement: a case series and review of literature. JPEN J Parenter Enteral Nutr (2010) 0.94
Does young age influence the prognosis of colorectal cancer: a population-based analysis. World J Surg Oncol (2014) 0.94
Summary of guidelines for infection prevention and control for flexible gastrointestinal endoscopy. Can J Gastroenterol (2013) 0.93
Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists. Can J Gastroenterol (2013) 0.93
Dorsal epidural intervertebral disk herniation with atypical radiographic findings: case report and literature review. J Spinal Cord Med (2010) 0.93
Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region. Can J Gastroenterol Hepatol (2015) 0.92
Colonoscopy and colorectal cancer incidence and mortality. Gastroenterol Clin North Am (2013) 0.92
Practice and documentation of performance of colonoscopy in a central Canadian health region. Can J Gastroenterol Hepatol (2014) 0.89
Prevalence of and outcomes associated with corticosteroid prescription in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.88
Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One (2013) 0.87
Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology. Can J Gastroenterol (2013) 0.87
Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis. Cancer Metastasis Rev (2013) 0.86
Synthetic lethal targeting of superoxide dismutase 1 selectively kills RAD54B-deficient colorectal cancer cells. Genetics (2013) 0.86
Canadian Association of Gastroenterology policy on the application for, and implementation of, clinical practice guidelines. Can J Gastroenterol Hepatol (2014) 0.85
Congenital atresia of left main coronary artery. Indian Heart J (2005) 0.85
Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis. J Oncol Pract (2012) 0.84
Patient satisfaction with the endoscopy experience and willingness to return in a central Canadian health region. Can J Gastroenterol (2013) 0.83
Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies. Can J Gastroenterol Hepatol (2015) 0.83
Use of fecal occult blood testing in hospitalized patients: results of an audit. Can J Gastroenterol Hepatol (2014) 0.83
Synthetic genetic targeting of genome instability in cancer. Cancers (Basel) (2013) 0.83
Traumatic epistaxis: Skull base defects, intracranial complications and neurosurgical considerations. Int J Surg Case Rep (2013) 0.81
From ABCs to GRADE: Canadian Task Force on Preventive Health Care's new rating system for clinical practice guidelines. Can Fam Physician (2013) 0.81
Isolation of the left subclavian artery. Indian Heart J (2003) 0.79
Incidence of right-sided colorectal cancer after breast cancer: a population-based study. Am J Gastroenterol (2009) 0.78
Challenges of population-based colorectal cancer screening and the importance of time-trend analysis when evaluating system change. Cancer Epidemiol (2013) 0.77
Does geography influence the treatment and outcomes of colorectal cancer? A population-based analysis. World J Surg Oncol (2013) 0.77
The practice of gastrostomy tube placement across a Canadian regional health authority. Am J Gastroenterol (2010) 0.77
Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival. J Surg Oncol (2013) 0.76
Sister chromatid cohesion defects are associated with chromosome instability in Hodgkin lymphoma cells. BMC Cancer (2013) 0.76
Colonoscopic screening for colorectal cancer. JAMA (2006) 0.76
Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic. Inflamm Bowel Dis (2016) 0.76
Primary spinal germ cell tumors: a case analysis and review of treatment paradigms. Case Rep Med (2013) 0.75
Screening colonoscopy vs flexible sigmoidoscopy. JAMA (2010) 0.75
Flexible sigmoidoscopy for colorectal cancer screening in Canada. Can J Gastroenterol Hepatol (2014) 0.75
Giant aneurysm of coronary artery. Indian Heart J (2008) 0.75
Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 0.75
Cervical screening. CMAJ (2013) 0.75
Response to letter to the editor. Can J Gastroenterol Hepatol (2014) 0.75
Inequities in colonoscopy: variation in performance and outcomes of colonoscopy. Gastrointest Endosc (2009) 0.75
Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis. Inflamm Bowel Dis (2017) 0.75
Health Care Services in IBD: Factors Associated with Service Utilization and Preferences for Service Options for Routine and Urgent Care. Inflamm Bowel Dis (2017) 0.75
Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the Development of IBD: A Population-Based Analysis. Inflamm Bowel Dis (2017) 0.75
Role of 30 kDa antigen of enteric bacterial pathogens as a possible arthritogenic factor in post-dysenteric reactive arthritis. Indian J Pathol Microbiol (2013) 0.75
Health Care Services in IBD: Factors Associated with Service Utilization and Preferences for Service Options for Routine and Urgent Care. Inflamm Bowel Dis (2017) 0.75
Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study. Inflamm Bowel Dis (2016) 0.75
Prosthetic aortic valve endocarditis due to Ochrobactrum anthropi. Indian J Med Sci (2011) 0.75
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study. Am J Gastroenterol (2017) 0.75
Percutaneous transluminal angioplasty in an embolic middle cerebral artery occlusion. Indian Heart J (2005) 0.75
Epilepsy in Punjab (India): A Population-Based Epidemiologic Study. Neuroepidemiology (2015) 0.75
Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.75